期刊
CHEST
卷 122, 期 5, 页码 1858-1860出版社
AMER COLL CHEST PHYSICIANS
DOI: 10.1378/chest.122.5.1858
关键词
drug injury; etanercept; granulomatous inflammation; inflammatory lung disease; rheumatoid arthritis
Etanercept is the first anticytokine drug approved to treat rheumatoid arthritis. Side effects are infrequent, the most common being local skin reactions, headaches, and upper respiratory tract symptoms. We report the first case of lung injury that occurred while receiving this agent. Biopsy specimens of lung and skin lesions demonstrated noneaseating granulomas associated with a microscopic particulate. Withdrawal of etanercept achieved clinical stabilization, and the addition of prednisone resulted in rapid improvement.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据